tert-butyl 3-amino-6-methyl-2H,4H,5H,6H-pyrrolo[3,4-c]pyrazole-5-carboxylate, 98%, 1g

1-Iodo-4-nitrobenzene, 95.0%, 1g

(6-Methylpyridin-3-yl)methanamine dihydrochloride, 95.0%, 2g

1-(5-chloro-2-methoxyphenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

3-Chloro-4,5-difluoropyridine, 97%, 100mg

2,9-Dichloro-4,7-diphenyl-1,10-phenanthroline, 95.0%, 1g

DL-alpha-Lipoic Acid>99.0%(T)5g

4-(TERT-BUTYL)-N-(6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)-[2,2'-BIPYRIMIDIN]-4-YL)BENZENESULFONAMIDE, 95%, 5g

(R)-Tetrahydro-2H-pyran-3-ol, 95.0%, 5g

3-Bromo-4-methylpicolinonitrile, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid, 95.0%, 5g

((Chloromethyl)sulfonyl)benzene, 95.0%, 250mg

E-Plan phase EPLPH 20x/0.40 objective. Working distance 1.85 mm